Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss
Year: 2026
Type: article
Study design: Observational Study
Abstract: This cross-sectional study uses data from Medicaid State Drug Utilization Data to examine associations of coverage withdrawal with Medicaid beneficiaries’ utilization of weight loss–approved glucagon-like peptide-1s.
Source: JAMA
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Lowering Cardiovascular Disease Among People with Opioid Use Disorder, Optimizing prescribing decisions for hospitalized older adults with chronic conditions, Impact of high deductible health plans and the 2020 public health emergency on alcohol use disorder treatment access, outcomes, and subpopulations
OpenAlex ID: W7234051062
